|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/417 | |
| A61K 9/00 | |||
| A61P 27/02 |
| (11) | Number of the document | 2950800 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14746563.7 |
| Date of filing the European patent application | 2014-01-31 | |
| (97) | Date of publication of the European application | 2015-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/014070 |
| Date | 2014-01-31 |
| (87) | Number | WO 2014/121028 |
| Date | 2014-08-07 |
| (30) | Number | Date | Country code |
| 201361759542 P | 2013-02-01 | US |
| (72) |
MEYER, Alan, US
|
| (73) |
Ocuphire Pharma, Inc.,
6894 Lakemont Circle, West Bloomfield, MI 48323,
US
|
| (54) | METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE |
| METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE |